Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
Baricitinib found effective for moderate to severe AD out to 52 weeks
At weeks 16, 32, and 52, the proportion of patients who achieved an EASI75 response was 40%, 51%, and 49%, respectively.
News
Ruxolitinib cream for atopic dermatitis found to be effective, safe up to 52 weeks
Treatment-related adverse events were reported in 5% of patients who applied 0.75% ruxolitinib cream and in 3% of patients who applied 1.5%...
News
Survey spotlights the out-of-pocket burden on Blacks with atopic dermatitis
The findings “provide another piece of evidence for increased financial burden among black individuals with AD and support the need for targeted...
News
HIFEM procedure helped to improve UI and female sexual function
“This is a true paradigm shift in the treatment of incontinence and sexual dysfunction,” Dr. Joseph Berenholz said.
News
12-month follow-up shows monthly maintenance dose of tralokinumab maintains response in some AD patients
“There may be a population of patients who require the drug every 4 weeks after initially receiving the drug every 2 weeks for the first 16 weeks...
News
1 in 15 patients who start dupilumab may develop conjunctivitis, large analysis finds
“Compared to AD patients who received treatment with other systemic agents, dupilumab treatment doubled the risk of conjunctivitis in clinical...
News
Trial offers first look at how tralokinumab-treated patients weather COVID-19
The average duration of COVID-19 infection was 15 days and severity of disease was mild in 35 patients (69%), moderate in 14 (27%), and severe in...
News
Photobiomodulation: Evaluation in a wide range of medical specialties underway
The therapy is used to treat a wide variety of medical and aesthetic disorders including acne vulgaris, psoriasis, burns, and wound healing.
News
Expert offers 10 ‘tips and tricks’ for everyday cosmetic practice
“Trust your clinical insight because this will serve you in the long term,” Dr. H. Ray Jalian said.
News
Expert shares her tips for an effective cosmetic consultation
“It’s important to look for any warning signs like irrational behavior or unrealistic expectations.”
News
Pilot study: Hybrid laser found effective for treating genitourinary syndrome of menopause
Further studies are important to improve the understanding of "laser dosimetry, frequency of treatments, and longevity of effect.
News
Trial yields evidence that laser resurfacing may prevent NMSC in aged skin
Three months following fractionated laser resurfacing, the ratio of AKs on treated vs. untreated arms was reduced fourfold.
News
One year after a single RAP treatment, patients give the results high marks
Of the 43 patients, 30 (69.8%) strongly agreed and 13 (30.2%) agreed that their cellulite “appears improved.”
News
FDA approves secukinumab in psoriasis patients age six and older
“This has changed the playing field for these children and their families completely.”
News
Avoiding excess oxygen in mechanically ventilated patients ‘seems sensible’
Future trials “will have to address how a particular [oxygenation] target is both set and achieved in each group of patients, particularly those...